GlassScriptPhysician profile
Cyrus B Noble
NPI 1588622757
$3,569.03
in general payments reported to CMS, 2019-2025
16 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $92.31 · 2021: $239 · 2022: $1,029 · 2023: $378 · 2024: $215 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $833 · Food and Beverage: $802 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $832.82 |
| Food and Beverage | $801.52 |
| Education | $170.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,170.77 | 2019-2025 | Lumenis Pulse 120h |
| Teleflex LLC | $1,101.79 | 2022-2024 | Urolift |
| Coloplast Corp | $454.65 | 2019-2021 | |
| Astellas Pharma US INC | $261.69 | 2019-2023 | |
| Myriad Genetic Laboratories, INC. | $181.82 | 2022-2024 | Myrisk |
| Endo USA, INC. | $108.24 | 2024-2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $61.97 | 2019-2024 | Xiaflex, Aveed |
| Axonics, INC. | $44.27 | 2023 | Axonics |
| Pfizer INC. | $35.63 | 2019-2021 | |
| Neotract INC. | $32.62 | 2020 | |
| Immunitybio, INC. | $31.34 | 2024 | |
| Chiesi USA, INC. | $24.49 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.53 | 2024 | Adstiladrin |
| Janssen Biotech, INC. | $15.15 | 2019 | |
| Blue Earth Diagnostics | $14.09 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $13.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cyrus Noble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.